Lovaza Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Lovaza General Information
Description
Manufacturer of Omega-3 supplements intended to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.
Contact Information
Website
lovaza.comFormerly Known As
Omacor
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
- 47220 Cartier Drive
- Suite A
- Wixom, MI
- United States
+1 (248)
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Parent Company
Corporate Office
- 47220 Cartier Drive
- Suite A
- Wixom, MI
- United States
+1 (248)
Lovaza Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lovaza Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lovaza FAQs
-
When was Lovaza founded?
Lovaza was founded in 2005.
-
Where is Lovaza headquartered?
Lovaza is headquartered in Wixom, MI.
-
What industry is Lovaza in?
Lovaza’s primary industry is Pharmaceuticals.
-
Is Lovaza a private or public company?
Lovaza is a Private company.
-
What is Lovaza’s current revenue?
The current revenue for Lovaza is .
-
Who are Lovaza’s investors?
GSK has invested in Lovaza.
-
When was Lovaza acquired?
Lovaza was acquired on 17-Aug-2021.
-
Who acquired Lovaza?
Lovaza was acquired by Woodward Pharma Services.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process